Celecoxib and rofecoxib: efficacy and safety of selective inhibitors of Cox-2 compared to non-selective NSAIDs. Rev Port Med Geral Fam [Internet]. 2004 Jan. 1 [cited 2026 Apr. 19];20(1):47-64. Available from: https://rpmgf.pt/ojs/index.php/rpmgf/article/view/10008